Home

Preston Klassen, President & Head of R & D: Regulus Therapeutics RGLS Buy · Filed 25/06/04

Trade details

Type
Insider buy
Amount
$95,880
Shares · price
12,000 sh · $7.99 a share
Held after
48,055 sh
Trade date
25/06/03
Filed
25/06/04
Days to filing
1 days

First buy since 2023

Insiders buying this week
1 insiders
Holding change
+33.3%

Regulus Therapeutics trades, last 26 weeks

What else happened in Regulus Therapeutics around then

Filed or reported within 30 days of the trade day · 25/05/04~25/07/03

Preston Klassen's recent trades

  • Preston Klassen

    Sell10b5-1 planRegulus Therapeutics

    $39.6K

    Filed 25/01/15

  • Preston Klassen

    SellMetacrine

    $156K

    Filed 23/01/27